PTH
Showing 1 - 25 of 1,155
Near-Infrared Autofluorescence With PTH Test Strip asSOP of
Recruiting
- Thyroid Cancer
- +2 more
- Near-infrared devices
- PTH test strip
-
FuZhou, Fujian, ChinaFujian Medical University Union Hospital
Jan 4, 2023
Post-Surgical Hypoparathyroidism Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (encaleret)
Recruiting
- Post-Surgical Hypoparathyroidism
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 24, 2023
Hypoparathyroidism Trial (Palopegteriparatide (TransCon PTH))
Available
- Hypoparathyroidism
- Palopegteriparatide (TransCon PTH)
- (no location specified)
Jan 10, 2023
Odontoid Fracture Trial in Burlington (Abaloparatide, Hard collar immobilization)
Recruiting
- Odontoid Fracture
- Abaloparatide
- Hard collar immobilization
-
Burlington, VermontUniversity of Vermont Medical Center
Jun 21, 2022
Hypoparathyroidism, Parathyroid Hormone Deficiency, Endocrine System Diseases Trial in Beijing (TransCon PTH, )
Recruiting
- Hypoparathyroidism
- +3 more
- TransCon PTH
- placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 18, 2022
Thyroid Cancer, Goiter, Thyroiditis Trial in Medellin (calcium correction according to PTH levels, routine postoperative calcium
Not yet recruiting
- Thyroid Cancer
- +3 more
- calcium correction according to PTH levels
- routine postoperative calcium and calcitriol
-
Medellin, Antioquia, ColombiaIPS Universitaria
Mar 12, 2022
Osteoporotic Fractures Trial in New York (Teriparatide Prefilled Syringe, Placebo)
Completed
- Osteoporotic Fractures
- Teriparatide Prefilled Syringe
- Placebo
-
New York, New YorkHospital for Special Surgery
Jul 26, 2022
Preoperative Parathyroid Hormone and Ex-Vivo Gamma Counts in
Active, not recruiting
- Parathyroid Disease
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Feb 28, 2022
Menopause Trial (YesMilkdiet, NoMilkdiet)
Not yet recruiting
- Menopause
- YesMilkdiet
- NoMilkdiet
- (no location specified)
Sep 16, 2023
Vitamin D Deficiency, 25-Hydroxyvitamin D3 Deficiency, Selective Trial in Cuernavaca (vitamin D-enhanced egg, Control)
Completed
- Vitamin D Deficiency
- 25-Hydroxyvitamin D3 Deficiency, Selective
- vitamin D-enhanced egg
- Control
-
Cuernavaca, Morelos, MexicoInstituto Nacional de Salud Pública
Oct 19, 2023
Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)
Not yet recruiting
- Secondary Hyperparathyroidism
- PLS240
- +2 more
- (no location specified)
Apr 17, 2023
End Stage Renal Disease Trial in Shanghai (regular hemodialysis, hemoperfusion combined with hemodialysis)
Recruiting
- End Stage Renal Disease
- regular hemodialysis
- hemoperfusion combined with hemodialysis
-
Shanghai, Shanghai, ChinaChanghai Hospital
Feb 1, 2023
Healthy Trial in Kuala Lumpur (Placebo, 500 mg calcium, 600 IU vitamin D + 500 mg calcium, 1200 IU vitamin D + 500 mg calcium)
Completed
- Healthy
- Placebo, 500 mg calcium
- +3 more
-
Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaInternational Medical University
Mar 10, 2022
Secondary Hyperparathyroidism, End Stage Kidney Disease Trial (PLS240, Placebo, Open-Label Extension PLS240)
Not yet recruiting
- Secondary Hyperparathyroidism
- End Stage Kidney Disease
- PLS240
- +2 more
- (no location specified)
Apr 18, 2023
End Stage Renal Disease Trial in Linz (Etelcalcetide)
Completed
- End Stage Renal Disease
-
Linz, Upper Austria, AustriaOrdensklinikum Linz GmbH Elisabethinen
Mar 22, 2022
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo for TransCon PTH)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo for TransCon PTH
-
Chicago, Illinois
- +14 more
Mar 2, 2022
Chronic Kidney Disease Requiring Chronic Dialysis Trial in Vienna
Completed
- Chronic Kidney Disease Requiring Chronic Dialysis
-
Vienna, AustriaMedical University of Vienna
Sep 1, 2021
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo
-
San Francisco, California
- +20 more
Aug 5, 2022
Exercise, Bone Resorption, Bone Formation Trial in Aurora (Endurance exercise intervention)
Recruiting
- Exercise
- +2 more
- Endurance exercise intervention
-
Aurora, ColoradoRocky Mountain Regional VA Medical Center, Aurora, CO
Apr 11, 2022
Stress Fracture Trial in Norwich (Teriparatide)
Completed
- Stress Fracture
-
Norwich, Norfolk, United KingdomNorfolk and Norwich University Hospitals Foundation Trust
Aug 5, 2021
Moderate to Severe Secondary Hyperparathyroidism, Stage 5 Chronic Kidney Diseases Trial (Paricalcitol, Darbepoetin alfa)
Completed
- Moderate to Severe Secondary Hyperparathyroidism
- Stage 5 Chronic Kidney Diseases
- Paricalcitol
- Darbepoetin alfa
- (no location specified)
Jul 28, 2021
Male Osteoporosis Trial in San Francisco (Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, tablet)
Recruiting
- Male Osteoporosis
- Teriparatide or human parathyroid hormone (PTH) 1-34
- +4 more
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Dec 8, 2021
Care for Secondary Fracture Prevention
Recruiting
- Osteoporosis
- Biochemical markers i.e. Serum Ca, PTH, CTX, Albumin, Phosphate, Vitamin D and Bone mineral density Scan
-
Karachi, Sindh, PakistanAga Khan University
Apr 18, 2022